|Cyclin D1, Id1 and EMT in breast cancer|
NP Tobin, AH Sims, KL Lundgren, S Lehn, G Landberg
BMC cancer 11 (1), 417, 2011
|Digital image analysis outperforms manual biomarker assessment in breast cancer|
G Stålhammar, NF Martinez, M Lippert, NP Tobin, I Mølholm, L Kis, ...
Modern Pathology 29 (4), 318-329, 2016
|Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features|
S Lehn, NP Tobin, P Berglund, K Nilsson, AH Sims, K Jirström, ...
The American journal of pathology 177 (6), 2886-2897, 2010
|Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival|
NP Tobin, JC Harrell, J Lövrot, S Egyhazi Brage, M Frostvik Stolt, ...
Annals of oncology 26 (1), 81-88, 2015
|Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling|
O Frings, M Augsten, NP Tobin, J Carlson, J Paulsson, C Pena, E Olsson, ...
The American journal of pathology 182 (6), 2037-2047, 2013
|The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer|
NP Tobin, T Foukakis, L De Petris, J Bergh
Journal of internal medicine 278 (6), 545-570, 2015
|Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades|
LJ Esserman, C Yau, CK Thompson, LJ Van't Veer, AD Borowsky, ...
JAMA oncology 3 (11), 1503-1510, 2017
|Role of tumor pericytes in the recruitment of myeloid-derived suppressor cells|
JW Hong, NP Tobin, H Rundqvist, T Li, M Lavergne, Y García-Ibáñez, ...
Journal of the National Cancer Institute 107 (10), djv209, 2015
|Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications|
S Kimbung, A Kovács, A Danielsson, PO Bendahl, K Lövgren, MF Stolt, ...
Oncotarget 6 (32), 33306, 2015
|Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response|
S Lehn, NP Tobin, AH Sims, O Stål, K Jirström, H Axelson, G Landberg
BMC cancer 14 (1), 119, 2014
|Guidance molecule SEMA3A restricts tumor growth by differentially regulating the proliferation of tumor-associated macrophages|
M Wallerius, T Wallmann, M Bartish, J Östling, A Mezheyeuski, NP Tobin, ...
Cancer research 76 (11), 3166-3178, 2016
|Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction|
NP Tobin, GT Henehan, RP Murphy, JC Atherton, AF Guinan, ...
American Journal of Physiology-Heart and Circulatory Physiology 295 (4 …, 2008
|High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer|
J Paulsson, L Rydén, C Strell, O Frings, NP Tobin, T Fornander, J Bergh, ...
The Journal of Pathology: Clinical Research 3 (1), 38-43, 2017
|Analysis of Cyclin D1 in breast cancer: a call to arms|
NP Tobin, J Bergh
Current breast cancer reports 4 (3), 171-173, 2012
|Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients|
NP Tobin, LS Lindström, JW Carlson, J Bjöhle, J Bergh, K Wennmalm
Molecular oncology 8 (3), 741-752, 2014
|Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer|
K Lundgren, NP Tobin, S Lehn, O Stål, L Rydén, K Jirström, G Landberg
The Journal of Molecular Diagnostics 13 (3), 340-351, 2011
|Down-regulation of neprilysin (EC3. 4.24. 11) expression in vascular endothelial cells by laminar shear stress involves NADPH oxidase-dependent ROS production|
PA Fitzpatrick, AF Guinan, TG Walsh, RP Murphy, MT Killeen, NP Tobin, ...
The international journal of biochemistry & cell biology 41 (11), 2287-2294, 2009
|Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information|
NP Tobin, KL Lundgren, C Conway, L Anagnostaki, S Costello, ...
Human pathology 43 (11), 2053-2061, 2012
|Gene expression signatures and immunohistochemical subtypes add prognostic value to each other in breast cancer cohorts|
A Lundberg, LS Lindström, JC Harrell, C Falato, JW Carlson, PK Wright, ...
Clinical Cancer Research 23 (24), 7512-7520, 2017
|Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer|
S Robertson, G Stålhammar, E Darai-Ramqvist, M Rantalainen, NP Tobin, ...
Journal of clinical pathology 71 (9), 787-794, 2018